The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME)

Transfusion

Volumn 53, Issue 9, 2013, Pages 1930-1939

  Doodeman, Hieronymus J ^a   Van Haelst, Ingrid M M ^a   Egberts, Toine C G ^a   Bennis, Martin ^a   Traast, Han S ^a   Van Solinge, Wouter W ^a   Kalkman, Cor J ^a   Van Klei, Wilton A ^a  

^a Location Alkmaar

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

AGED; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD TRANSFUSION; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84883892596     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12016     Document Type: Article

References (37)

1. Spahn DR,. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 482-495.
2. The Sanguis Study Group. Use of blood products for elective surgery in 43 European hospitals. Transfus Med 1994; 4: 251-268.
3. Hutton B, Fergusson D, Tinmouth A, McIntyre L, Kmetic A, Hebert PC,. Transfusion rates vary significantly amongst Canadian medical centres. Can J Anaesth 2005; 52: 581-590.
4. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB,. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-937.
5. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM,. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102: 237-244.
6. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD,. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-2552.
7. Atzil S, Arad M, Glasner A, Abiri N, Avraham R, Greenfeld K, Rosenne E, Beilin B, Ben Eliyahu S,. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology 2008; 109: 989-997.
8. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH,. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.
9. Shander A, Van Aken H, Colomina MJ, Gombotz H, Hofmann A, Krauspe R, Lasocki S, Richards T, Slappendel R, Spahn DR,. Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68.
10. Beattie WS, Karkouti K, Wijeysundera DN, Tait G,. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-581.
11. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR,. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-1407.
12. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M,. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
13. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 341: 1227-1232.
14. de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC,. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996; 25: 533-542.
15. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY,. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000; 133: 845-854.
16. Horstmann WG, Ettema HB, Verheyen CC,. Dutch orthopedic blood management surveys 2002 and 2007: an increasing use of blood-saving measures. Arch Orthop Trauma Surg 2010; 130: 55-59.
17. Mohyeldin A, Lu H, Dalgard C, Lai SY, Cohen N, Acs G, Verma A,. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 2005; 7: 537-543.
18. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF,. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 2010; 153: 23-33.
19. Rupertus K, Sperling J, Corsten M, Scheuer C, Nickels RM, Schilling MK, Menger MD, Kollmar O,. Darbepoetin-alpha enhances hepatectomy-associated stimulation of colorectal liver metastatic growth. Ann Surg 2010; 252: 131-141.
20. Unger EF, Thompson AM, Blank MJ, Temple R,. Erythropoiesis-stimulating agents-time for a re-evaluation. N Engl J Med 2010; 362: 189-192.
21. Van Zuiden Communications BV AadRtN. CBO richtlijn bloedtransfusie 2004, kwaliteitsinstituut voor de gezondheidszorg. CBO 2011.
22. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D,. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27: 299-309.
23. Moonen AF, Neal TD, Pilot P,. Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature. Injury 2006; 37 Suppl 5: S11-S16.
24. Waters JH, Dyga RM, Waters JF, Yazer MH,. The volume of returned red blood cells in a large blood salvage program: where does it all go? Transfusion 2011; 51: 2126-2132.
25. Sajwani FH,. Improving blood transfusion practice by regular education in the United Arab Emirates. Transfusion 2012; 52: 1628-1631.
26. Shehata N, Burns LA, Nathan H, Hebert P, Hare GM, Fergusson D, Mazer CD,. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012; 52: 91-99.
27. Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF,. Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study. Transfusion 2010; 50: 2117-2124.
28. Carless P, Moxey A, O'Connell D, Henry D,. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 2004; 14: 123-144.
29. Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M,. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006; 46: 1112-1119.
30. Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H,. The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. BJU Int 2011; 108: 1582-1587.
31. College ter Beoordeling van Geneesmiddelen [Medicines Evaluation Board]. Summary of product characteristics (SPC). EPREX. [cited 2012 Sep 29]. Available from: URL: http://www.cbg-meb.nl
32. Garcia-Erce JA, Cuenca J, Haman-Alcober S, Martinez AA, Herrera A, Munoz M,. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang 2009; 97: 260-267.
33. Stowell CP, Jones SC, Enny C, Langholff W, Leitz G,. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine 2009; 34: 2479-2485.
34. Morgan TO,. Blood conservation: the CEO perspective. J Cardiothorac Vasc Anesth 2004; 18: 15S-17.
35. Coyle D, Lee KM, Fergusson DA, Laupacis A,. Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med 1999; 9: 21-30.
36. Green WS, Toy P, Bozic KJ,. Cost minimization analysis of preoperative erythropoietin vs. autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplasty 2010; 25: 93-96.
37. Keating EM, Ritter MA,. Transfusion options in total joint arthroplasty. J Arthroplasty 2002; 17: 125-128.